Investigating how the location of deep brain stimulation affects movement in Parkinson's disease
Official title: Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease; Udall Project 2 Aims 1 & 2
Run by University of Minnesota · NCT05557864 · Data updated 2026-11-12
This study tests how different locations for deep brain stimulation can improve movement in people with Parkinson's disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 89 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Status | Recruiting |
| Started | August 25, 2016 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | January 26, 2026 |
| Trial ID | NCT05557864 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with idiopathic Parkinson's disease who have already undergone DBS surgery.
✕Probably not a fit
Patients with significant musculoskeletal disorders, other neurological conditions, or cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the impact of the specific location of deep brain stimulation (DBS) on motor impairments in individuals with Parkinson's disease. By analyzing both the beneficial and adverse effects of DBS in the globus pallidus and subthalamic nucleus, the research seeks to tailor stimulation protocols to better meet individual patient needs. The findings could lead to improved treatment strategies for motor symptoms that do not respond well to standard dopamine therapy.
Why it matters
Potential benefit: If successful, this study could provide a new approach to managing motor symptoms in Parkinson's disease that are resistant to current treatments.
How similar studies have gone: Other studies have shown promise in using deep brain stimulation for Parkinson's disease, but this specific approach focusing on stimulation location is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosis of idiopathic PD * have undergone neurosurgery to implant deep brain stimulators in the globus pallidus (GP DBS) or subthalamic nucleus (STN) * Existing 7T brain imagery Exclusion Criteria: * history of musculoskeletal disorders that significantly affect movement of the upper or lower limbs * other significant neurological disorder * history of dementia or cognitive impairment as found with UBACC (or MacCAT-CR) * post-operative complications or adverse effects
Where it's running
-
University Of Minnesota
Minneapolis, Minnesota, United States Recruiting
Study contacts
- Study coordinator: Colum MacKinnon, PhD
- Email: cmackinn@umn.edu
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder
This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.
-
Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment
This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.
-
Mental imagery with self-regulation to help daily activities in Parkinson's disease
This study tests whether a six-week program of mental imagery combined with self-regulation can help people with Parkinson’s perform daily activities better than standard learning or exercise.
-
Real-world experiences of Inbrija for Parkinson's OFF episodes
This study looks at how people with Parkinson’s who use Inbrija for OFF episodes feel and function in daily life.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
Test of RO7568282 in early Parkinson's disease
This study tests whether RO7568282, compared with placebo, is safe and helps people with early Parkinson's disease who are already taking levodopa.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.